New Jersey Medical School
Cepheid Collaborator at Rutgers-NJMS Wins NIH Award to Further Develop Highly Multiplexed TB Assay
Premium
The laboratory of David Alland at Rutgers Biomedical and Health Sciences' New Jersey Medical School has been awarded a five-year grant from the National Institutes of Health to further develop a highly multiplexed assay to detect multiple drug-resistant strains of tuberculosis us
Having recently secured funding from a private investor, moved to the San Francisco Bay Area, and obtained the rights to a key patent covering its core nucleic acid probe technology, molecular diagnostics startup QuanDx is now shifting its attention toward developing clinical ass
UMDNJ Group Develops 'Super' Selective Primer Tech for Low-Level qPCR-Based Mutation Detection
Premium
SAN FRANCISCO — Researchers from the University of Medicine and Dentistry of New Jersey and New Jersey Medical School this week unveiled a new qPCR-based mutation-detection chemistry at Cambridge Healthtech Institute's Molecular Medicine Tri-Conference held here.
The Institute for Genomic Medicine at the University of Medicine and Dentistry of New Jersey has launched a Cystic Fibrosis Carrier and Diagnosis Test on the Ion Torrent PGM.